Dataset Information

Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.

ABSTRACT: The mechanism underlying the dysregulation of cholesterol metabolism and inflammation in atherogenesis is not understood fully. Glycine N-methyltransferase (GNMT) has been implicated in hepatic lipid metabolism and the pathogenesis of liver diseases. However, little is known about the significance of GNMT in atherosclerosis. We showed the predominant expression of GNMT in foamy macrophages of mouse atherosclerotic aortas. Genetic deletion of GNMT exacerbated the hyperlipidemia, inflammation and development of atherosclerosis in apolipoprotein E-deficient mice. In addition, ablation of GNMT in macrophages aggravated oxidized low-density lipoprotein-mediated cholesterol accumulation in macrophage foam cells by downregulating the expression of reverse cholesterol transporters including ATP-binding cassette transporters-A1 and G1 and scavenger receptor BI. Furthermore, tumor necrosis factor-?-induced inflammatory response was promoted in GNMT-null macrophages. Collectively, our data suggest that GNMT is a crucial regulator in cholesterol metabolism and in inflammation, and contributes to the pathogenesis of atherosclerosis. This finding may reveal a potential therapeutic target for atherosclerosis.

SUBMITTER: Chen CY

PROVIDER: S-EPMC3409278 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.

Chen Chien-Yu CY Ching Li-Chieh LC Liao Yi-Jen YJ Yu Yuan-Bin YB Tsou Chia-Yuan CY Shyue Song-Kun SK Chen Yi-Ming Arthur YM Lee Tzong-Shyuan TS

Molecular medicine (Cambridge, Mass.) 20120718

The mechanism underlying the dysregulation of cholesterol metabolism and inflammation in atherogenesis is not understood fully. Glycine N-methyltransferase (GNMT) has been implicated in hepatic lipid metabolism and the pathogenesis of liver diseases. However, little is known about the significance of GNMT in atherosclerosis. We showed the predominant expression of GNMT in foamy macrophages of mouse atherosclerotic aortas. Genetic deletion of GNMT exacerbated the hyperlipidemia, inflammation and ...[more]

PMID: 22415010

Similar Datasets

Project description:Macrophages play a pivotal role in atherosclerotic plaque development. Recent evidence has suggested the glucagon-like peptide-1 receptor (GLP-1R) agonist, liraglutide, can attenuate pro-inflammatory responses in macrophages. We hypothesized that liraglutide could limit atherosclerosis progression in vivo via modulation of the inflammatory response.Human THP-1 macrophages and bone marrow-derived macrophages, from both wild-type C57BL/6 (WT) and apolipoprotein E null mice (ApoE-/-) were used to investigate the effect of liraglutide on the inflammatory response in vitro. In parallel, ApoE-/- mice were fed a high-fat (60% calories from fat) high-cholesterol (1%) diet for 8 weeks to induce atherosclerotic disease progression with/without daily 300 ?g/kg liraglutide administration for the final 6 weeks. Macrophages were analysed for M?1 and M?2 macrophage markers by Western blotting, RT-qPCR, ELISA and flow cytometry. Atherosclerotic lesions in aortae from ApoE-/- mice were analysed by en face staining and monocyte and macrophage populations from bone marrow derived cells analysed by flow cytometry.Liraglutide decreased atherosclerotic lesion formation in ApoE-/- mice coincident with a reduction in pro-inflammatory and increased anti-inflammatory monocyte/macrophage populations in vivo. Liraglutide decreased IL-1beta in M?0 THP-1 macrophages and bone marrow-derived macrophages from WT mice and induced a significant increase in the M?2 surface marker mannose receptor in both M?0 and M?2 macrophages. Significant reduction in total lesion development was found with once daily 300 ?g/kg liraglutide treatment in ApoE-/- mice. Interestingly, liraglutide inhibited disease progression at the iliac bifurcation suggesting that it retards the initiation and development of disease. These results corresponded to attenuated M?1 markers (CCR7, IL-6 and TNF-alpha), augmented M?2 cell markers (Arg-1, IL-10 and CD163) and finally decreased M?1-like monocytes and macrophages from bone marrow-derived cells.This data supports a therapeutic role for liraglutide as an atheroprotective agent via modulating macrophage cell fate towards M?2 pro-resolving macrophages.

Dataset Information

Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.

Publications

Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets